<DOC>
	<DOC>NCT00185484</DOC>
	<brief_summary>The purpose of this study is to determine whether the study drug is effective in prevention of pregnancy in healthy women in reproductive age</brief_summary>
	<brief_title>Efficacy and Safety Oral Contraceptive Study</brief_title>
	<detailed_description>The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.</detailed_description>
	<mesh_term>Drospirenone</mesh_term>
	<mesh_term>Contraceptives, Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Healthy woman requesting contraception Age between 18 and 35 years (inclusive), smokers maximum age of 30 years (inclusive) Any conditions might interfere study outcome</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Oral contraception</keyword>
</DOC>